Investor Resources
CSE: PMED
OTC MARKETS: PMEDF
FRA: 3QP
About Predictmedix
Predictmedix is a Life Sciences technology company developing AI-powered products to improve workplace health and safety, enhance protection in public environments, and provide tools for medical professionals to better care for patients.
Our Team
Dr. Rahul Kushwah
COO, Director
PhD, Banting Fellow. Developed world’s first genetic test for cannabis pharmacogenetics. Previously on the National Research Council for the Government of Canada in Human Health Therapeutics. Expertise in human diseases, genetics, immunology and regenerative/personalized
Sheldon Kales
CEO, Director
Expertise in operations, business strategy and capital markets. Held leadership roles operating R&D companies in the USA, Canada and the Middle East. Led companies from start-up stages through growth and successful
Kapil Raval
Advisory Board Chair, Director of AI, Business Development, Microsoft
Global Business Leader with 25+ years experience. Kapil is currently a director at Microsoft, driving business development for AI solutions for different industries globally. Having worked for global organizations like Philips, DEC, Compaq and HPE & Microsoft in Americas, Middle East and APJ, Kapil brings understanding of global cultural & market nuances, inventiveness & problem-solving
Nandan Mishra
Co-AI Lead
Artificial Intelligence pioneer in translational research for AI. Masters in Systems Biology and Bachelors Degree in Engineering from the Indian Institute of Technology. Member of the prestigious National Mission of Interdisciplinary Cyber Physical Systems of India (a federal technology think
Rajiv Muradia
VP of Technology
Mobilewellbeing Founder. Executive entrepreneur with experience in technology, management and business development. Successfully founded several companies and has helped a number of start-ups with their product strategy, positioning and technology
Tomas Sipos
Director
Seasoned investment banker. Has held several senior positions, including VP, Mergers and Acquisitions of Ernst & Young, Managing Director of Investment Banking at European Privatization & Investment Corporation and Senior Investment Banker for the International Finance Corporation. Presently, CFO for Pistil Partners Inc., and serves as a director of NATO Association of Canada Program
Himanshu Ujjawal Singh
Co-AI Lead
Specialization in Data Analytics and AI. Consulted with several multinational corporations in setting up their analytics practice in the field of telecom, healthcare, retail and workforce analytics. Expertise in data
Praveen Kumar
Data Analytics Lead
Specialization in Data Analytics, Machine Learning and Deep Neural Networks. Worked with several top Fortune 500 companies. Consulted with top financial corporations in
Ajit Kumar
Director
Seasoned healthcare business leader. Founder of K-Med Ltd.; among the largest suppliers of healthcare and medical equipment in the UK with operations in the Middle East, EU and
Dr. Mike Hart
Advisor
Dr. Mike Hart is well-known for his outspoken advocacy for medicinal cannabis, with both a medical degree from the Saba School of Medicine in the Netherlands Antilles (2010) and a family medicine residency from Western University (2012). He founded the first physician-led Cannabis Clinic in London
Dr. Alexander D. Bardon
CCCP (EM) Emergency Room physician for over 6 years. Expertise in infectious disease and screening. Works in 3 different hospital emergency departments: Norfolk General, St. Mary’s General and Grand River Hospital § Associate Clinical Professor at McMaster
Guru Seghal
Managing Director for India Operations
Recent Press
Predictmedix Unveils Revolutionary Fitness Scan Vertical for Athletes, Teams, and Sports Federations
Toronto, Ontario – May 17, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is proud to announce the launch of its ground-breaking fitness scan vertical tailored specifically for athletes, teams, and sports federations. Leveraging state-of-the-art AI […]
Predictmedix Launches AI-Driven Comprehensive Triage Solution with Expanded Vital Parameter Measurements for High Traffic Hospitals in Targeted Asian Region
Toronto, Ontario – May 10, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is proud to announce the launch of its ground-breaking complete triage solution. Predictmedix’s cutting-edge system encompasses a wide range of parameters, including 8 […]
Predictmedix Introduces Ground-breaking Technology for Cardiovascular Risk Management: Safe Entry Stations Now Measure Blood Pressure, Heart Rate Variability and Blood Oxygen Non-Invasively
Toronto, Ontario – April 19, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is proud to announce a significant advancement in its Safe Entry Stations. The Company’s AI-powered screening technology will now be able to take […]
